Based on the recent study a small reduction in PTEN gene expression can trigger cancer susceptibility, the higher level of PTEN in SNU-668 would play an enhanced role as a negative regulator of STAT3 and mTOR, consequently resulting in more significant molecular change of signaling (37). This evidence concerns the gene PTEN and cancer.